Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.71 |
| ▸ | LMNA | P02545 | 3/20 | 0.71 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.71 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.71 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.63 |
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.62 |
| ▸ | PPARG | P37231 | 7/20 | 0.62 |
| ▸ | PPARD | Q03181 | 7/20 | 0.62 |
| ▸ | PPARA | Q07869 | 7/20 | 0.62 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.62 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.62 |
| ▸ | TLR2 | O60603 | 2/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.62 |
| ▸ | FABP4 | P15090 | 2/20 | 0.62 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.62 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.62 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.62 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2348213 | 1.00 | TSHR (0.71) | TSHRLMNANFKB1PMP22SLC15A2 | |
| SCHEMBL2350916 | 1.00 | TSHR (0.71) | TSHRLMNANFKB1PMP22SLC15A2 | |
| SCHEMBL2348686 | 1.00 | TSHR (0.71) | TSHRLMNANFKB1PMP22SLC15A2 | |
| SCHEMBL561614 | 1.00 | TSHR (0.71) | TSHRLMNANFKB1PMP22SLC15A2 | |
| SCHEMBL230198 | 1.00 | TSHR (0.71) | TSHRLMNANFKB1PMP22SLC15A2 | |
| SCHEMBL2346285 | 1.00 | TSHR (0.71) | TSHRLMNANFKB1PMP22SLC15A2 | |
| SCHEMBL24538421 | 1.00 | TSHR (0.71) | TSHRLMNANFKB1PMP22SLC15A2 | |
| SCHEMBL2343659 | 1.00 | TSHR (0.71) | TSHRLMNANFKB1PMP22SLC15A2 | |
| SCHEMBL2346452 | 1.00 | TSHR (0.71) | TSHRLMNANFKB1PMP22SLC15A2 | |
| SCHEMBL2350035 | 1.00 | TSHR (0.71) | TSHRLMNANFKB1PMP22SLC15A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025003023-A1 | METHOD FOR PRODUCING A CARBOXYLIC ACID | EVONIK OPERATIONS GMBH (DE) | 2025-01-02 | — | — | WO | disclosed |
| US-11912997-B2 | RNAi agents for inhibiting expression of Superoxide Dismutase 1 (SOD1), compositions thereof, and methods of use | Arrowhead Pharmaceuticals, Inc. (US) | 2024-02-27 | — | — | US | disclosed |
| WO-2023150693-A2 | NEUREGULIN-4 ANALOGS AND METHODS OF USING THEREOF IN DISEASE TREATMENT | AVEXEGEN THERAPEUTICS, INC. (US) | 2023-08-10 | — | — | WO | disclosed |
| US-20230203100-A1 | COMPOSITIONS INCLUDING MULTI-AGONIST PEPTIDES AND METHODS OF MANUFACTURE AND USE | PEP2TANGO THERAPEUTICS INC. | 2023-06-29 | — | — | US | disclosed |
| US-20230143604-A1 | QW DOSING OF GIP RECEPTOR AGONIST PEPTIDE COMPOUNDS AND USES THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2023-05-11 | — | — | US | disclosed |
| US-20180000742-A1 | Pharmaceutical Composition for Oral Insulin Administration Comprising a Tablet Core and a Polyvinyl Alcohol Coating | NOVO NORDISK A/S (DK) | 2018-01-04 | — | — | US | disclosed |
| WO-2017197048-A1 | ALBUMIN BINDING CONJUGATE COMPOSITIONS AND METHODS OF MAKING AND USING SAME | AMUNIX OPERATING INC. (US) | 2017-11-16 | — | — | WO | disclosed |
| US-9688737-B2 | Protease stabilized acylated insulin analogues | NOVO NORDISK A/S (DK) | 2017-06-27 | — | — | US | disclosed |
| US-9688737-B2 | Protease stabilized acylated insulin analogues | NOVO NORDISK A/S (DK) | 2017-06-27 | — | — | US | disclosed |
| US-20170145059-A1 | Novel Amylin And Calcitonin Receptor Agonist | NOVO NORDISK AS (DK) | 2017-05-25 | — | — | US | disclosed |
| CN-1313428-C | Method for producing carboxylic acid | NAT INST OF ADVANCED IND SCIEN (JP) | 2007-05-02 | — | — | CN | disclosed |
| US-7186858-B2 | Method for producing carboxylic acid | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2007-03-06 | — | — | US | disclosed |
| US-20050215817-A1 | Method for producing carboxylic acid | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2005-09-29 | — | — | US | disclosed |
| CN-1671642-A | Process for producing carboxylic acid | NAT INST OF ADV IND & TECHNOL (JP) | 2005-09-21 | — | — | CN | disclosed |
| EP-1544190-A1 | METHOD FOR PRODUCING CARBOXYLIC ACID | National Institute of Advanced Industrial Science and Technology (JP) | 2005-06-22 | — | — | EP | disclosed |
| EP-0183612-B1 | BIS(PERFLUOROALKYL-2-ETHYLTHIO)-2,2-ACETALDEHYDES AND PROCESS FOR THEIR PREPARATION | ELF ATOCHEM S.A. (FR) | 1988-02-24 | — | — | EP | disclosed |
| EP-0183612-A1 | Bis(perfluoroalkyl-2-ethylthio)-2,2-acetaldehydes and process for their preparation | ELF ATOCHEM S.A. (FR) | 1986-06-04 | — | — | EP | disclosed |
| EP-0057975-B1 | PROCESS FOR PRODUCING POLYCONDENSATES OF OMEGA-OXYPENTADECONOIC ACID | Takasago Perfumery Co., Ltd. (JP) | 1985-08-14 | — | — | EP | disclosed |
| US-4419292-A | Process for producing polycondensates of ω-oxypentadecanoic acid | TAKASAGO PERFUMERY CO., LTD. (JP) | 1983-12-06 | — | — | US | disclosed |
| EP-0057975-A1 | Process for producing polycondensates of omega-oxypentadeconoic acid | Takasago Perfumery Co., Ltd. (JP) | 1982-08-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11912997-B2 | RNAi agents for inhibiting expression of Superoxide Dismutase 1 (SOD1), compositions thereof, and methods of use | SOD1, SOD3, SMN1; SMN2 | TSHR 4636/4885LMNA 2101/4885NFKB1 2722/4885 |
| US-20230143604-A1 | QW DOSING OF GIP RECEPTOR AGONIST PEPTIDE COMPOUNDS AND USES THEREOF | GIPR, GLP1R, GRPR | TSHR 84/4885LMNA 4542/4885NFKB1 4093/4885 |
| US-20230203100-A1 | COMPOSITIONS INCLUDING MULTI-AGONIST PEPTIDES AND METHODS OF MANUFACTURE AND USE | IAPP, GPR119, GIPR | TSHR 443/4885LMNA 2355/4885NFKB1 3464/4885 |
| US-20170145059-A1 | Novel Amylin And Calcitonin Receptor Agonist | SCTR, CALCRL, IAPP | TSHR 255/4885LMNA 2777/4885NFKB1 2694/4885 |
| US-20050215817-A1 | Method for producing carboxylic acid | ADH1C, HAO2, ALDH2 | TSHR 2104/4885LMNA 3596/4885NFKB1 1961/4885 |
| US-20180000742-A1 | Pharmaceutical Composition for Oral Insulin Administration Comprising a Tablet Core and a Polyvinyl Alcohol Coating | IAPP, SI, GPR119 | TSHR 1371/4885LMNA 2023/4885NFKB1 1298/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.